Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 27:18:117-120.
doi: 10.1016/j.jor.2019.11.038. eCollection 2020 Mar-Apr.

Total hip arthroplasty: Concerns and precautions in sickle-cell trait

Francesco Pisanu  1   2   1 , Marco Pes  1   2   1 , Gianfilippo Caggiari  1   2   1 , Sebastiano Ortu  1   2   1 , Maria Luisa Satta  2   1 , Veronica Amorese  1 , Carlo Doria  1
Affiliations

Total hip arthroplasty: Concerns and precautions in sickle-cell trait

Francesco Pisanu et al. J Orthop. .
No abstract available

Keywords: Complications; Hip arthroplasty; Management; Osteonecrosis; Sickle cell trait.

PubMed Disclaimer

Conflict of interest statement

All the authors have no conflict of interest to declare.

Figures

Fig. 1
Fig. 1
Due to the specific blood supply and lack of collateral circulation the femoral head is particularly susceptible to avascular necrosis in SCD.
Fig. 2
Fig. 2
Complete joint destruction due to bilateral stage IV osteonecrosis of femoral head in SCT; radiographic and CT showed collapse and resorption of femoral head associated to severe acetabular bone loss.
See this image and copyright information in PMC

References

    1. Steinberg M.H., Sebastiani P. Genetic modifiers of sickle cell disease. Am J Hematol. 2012;87(8):795–803. - PMC - PubMed
    1. Tsaras G., Owusu-Ansah A., OwusuaBoateng F., Amoateng-Adjepong Y. Complications associated with sickle cell trait: a brief narrative review, the American journal of medicine. Am J Med. 2009. 2009;122(6):507–512. - PubMed
    1. Almeida A., Roberts I. Bone involvement in sickle cell disease. Br J Haematol. 2005;129:482–490. - PubMed
    1. Key N.S., Derebail V.K. Sickle-cell trait: novel clinical significance. HematologyAmSocHematolEduc Program. 2010;2010:418–422. - PMC - PubMed
    1. Ballardini E., Tarocco A., Marsella M. Universal neonatal screening for sickle cell disease and other haemoglobinopathies in Ferrara. Italy. Blood Transfus. 2013;11(2):245–249. - PMC - PubMed

LinkOut - more resources